Combination therapy effective for neurological pain
|
Tweet
|
|
Combined treatment with morphine and gabapentin is more effective at lower doses than either agent alone at controlling neurological pain, according to a report in this week’s issue of The New England Journal of Medicine.
Drugs that are currently used to treat neurological pain are not entirely effective and have side effects that limit the dosage that can be administered, note Dr. Ian Gilron, from Queen’s University in Kingston, Ontario, and colleagues. Thus, there is a need for new drug combinations to combat this problem.
In a study of 57 patients who had painful diabetic neuropathy or neuralgia related to shingles were randomly assigned to receive sustained-release morphine; gabapentin; morphine plus gabapentin; or lorazepam as a placebo. Forty-one patients completed the five-week trial.
At the start of the study, the subjects had an average daily pain score of 5.72 on a 0 to 10 scale. With morphine plus gabapentin at the maxim-tolerated dose, the score improved to 3.06, but with the other treatments the score never fell below 3.70. Similar findings were obtained when the Short-Form McGill Pain Questionnaire was used for assess pain levels.
When given in combination, the maxim-tolerated doses of morphine and gabapentin were significantly lower than when the drugs were used alone, the investigators point out.
At maxim-tolerated doses, morphine plus gabapentin was more likely than gabapentin alone to be linked to constipation and more likely than morphine alone to be associated with dry mouth.
In a related editorial, Dr. Srinivasa N. Raja and Dr. Jennifer A. Haythornthwaite, from Johns Hopkins University in Baltimore, and colleagues comment that the findings clearly show the advantages of combination treatment with gabapentin and morphine. However, the perceived risks of addiction associated with morphine and the “fear of scrutiny by regulatory agencies may present barriers to the acceptance of this combination as first-line treatment.”
SOURCE: The New England Journal of Medicine, March 31, 2005.
Revision date: July 5, 2011
Last revised: by Sebastian Scheller, MD, ScD
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Child addicts at heart of Indonesia anti-smoking suit
- Full Story - - »»»
Miracle sweetener stevia may have a sour note
- Full Story - - »»»
Scientists turn skin cells into beating heart muscle
- Full Story - - »»»
Too many people get angioplasties, study suggests
- Full Story - - »»»
Viewers’ family background affects how they react to MTV shows ‘16 and Pregnant,’ ‘Teen Mom’
- Full Story - - »»»
Weight management in pregnancy with diet is beneficial and safe and can reduce complications
- Full Story - - »»»

